TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 2,116 | 691 | 368 |
Financial expenses | 0 | 1 | 0 |
Earnings before taxes | 209 | -677 | -726 |
EBITDA | 214 | -673 | -725 |
Total assets | 9,146 | 9,941 | 5,806 |
Current assets | 3,235 | 4,382 | 1,070 |
Current liabilities | 646 | 922 | 623 |
Equity capital | 8,500 | 9,019 | 5,184 |
- share capital | 241 | 263 | 208 |
Employees (average) | 10 | 9 | 8 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 92.9% | 90.7% | 89.3% |
Turnover per employee | 212 | 77 | 46 |
Profit as a percentage of turnover | 9.9% | -98.0% | -197.3% |
Return on assets (ROA) | 2.3% | -6.8% | -12.5% |
Current ratio | 500.8% | 475.3% | 171.7% |
Return on equity (ROE) | 2.5% | -7.5% | -14.0% |
Change turnover | 1,482 | 329 | 262 |
Change turnover % | 233% | 247% | |
Chg. No. of employees | 1 | 1 | -1 |
Chg. No. of employees % | 11% | -11% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.